Financhill
Back

Mirati Therapeutics Stock Predictions

Mirati Therapeutics Stock Forecast

  • Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 59.4% based on the past 9 years of stock performance.
  • Mirati Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Mirati Therapeutics Stock Undervalued?
    The current Mirati Therapeutics [MRTX] share price is $52.57. The Score for MRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • MRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Mirati Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 59.4% based on the past 9 years of stock performance.

Mirati Therapeutics Stock Rating

Buy
53
Mirati Therapeutics (MRTX) is a Buy

Is Mirati Therapeutics overpriced?

  • Mirati Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Mirati Therapeutics Stock Price History

Is MRTX stock going to rise?

  • The current trend is relatively stagnant and MRTX is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
mirati.com

52-Week Data

52-Week High:
124.81
52-Week Low:
32.96

Prediction Charts

Market Cap:
3.03B
Price in USD:
52.57
Volume:
1.01M
Beta:
1.23

Technical Analysis

SMA50:
54.31
SMA100:
61.89
SMA200:
64.16
52-Wk Change:
-55.39%

Stock Predictions

  • Is Mirati Therapeutics stock public?
    Yes, Mirati Therapeutics is a publicly traded company.
  • What is the Mirati Therapeutics stock quote today?
    The Mirati Therapeutics stock price is 52.57 USD today.
  • How to buy Mirati Therapeutics stock online?
    You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-17 42.38 44.00 44.19 41.45
Jan-18 44.66 44.69 45.28 43.95
Jan-19 44.69 42.98 44.69 42.44
Jan-20 43.40 45.66 45.80 42.93
Jan-23 46.05 47.91 48.59 45.51
Jan-24 47.57 49.36 50.62 46.76
Jan-25 48.59 49.22 49.25 47.55
Jan-26 49.74 51.06 51.35 48.88
Jan-27 50.73 53.09 53.60 50.73
Jan-30 52.80 51.81 53.99 51.13
Jan-31 52.25 53.41 55.29 52.24
Feb-1 53.47 52.69 53.47 49.39
Feb-2 53.66 54.26 55.15 52.95
Feb-3 53.11 52.57 53.55 51.62

Mirati Therapeutics Earnings

Mirati Therapeutics Earnings Report: Per Share Mirati Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mirati Therapeutics Forecast Revenue Growth

Mirati Therapeutics Stock Analysis: Historical quarterly revenues per share for Mirati Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.

* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.